Shenzhen Bioeasy Biotechnology Second Quarter 2024 Earnings: EPS: CN¥0.012 (vs CN¥0.099 loss in 2Q 2023)

Simply Wall St · 09/01 00:29

Shenzhen Bioeasy Biotechnology (SZSE:300942) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥67.2m (up 31% from 2Q 2023).
  • Net income: CN¥5.55m (up from CN¥41.6m loss in 2Q 2023).
  • Profit margin: 8.3% (up from net loss in 2Q 2023).
  • EPS: CN¥0.012 (up from CN¥0.099 loss in 2Q 2023).
earnings-and-revenue-history
SZSE:300942 Earnings and Revenue History September 1st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Shenzhen Bioeasy Biotechnology shares are up 6.8% from a week ago.

Risk Analysis

Before you take the next step you should know about the 2 warning signs for Shenzhen Bioeasy Biotechnology that we have uncovered.